Evaluating dopamine transporter activity with 99mTc-TRODAT-1 SPECT in drug-naive Tourette's adults

Nuclear Medicine Communications

Volumn 27, Issue 10, 2006, Pages 779-784

  Yeh, Chin Bin ^a   Lee, Chiang Hsuan ^a   Chou, Yuan Hwa ^a   Chang, Chia Jung ^b   Ma, Kuo Hsing ^b   Huang, Wen Sheng ^b  

^a CHI MEI MEDICAL CENTER   (Taiwan)

^b Nuclear Medicine   (Taiwan)

Author keywords

Dopamine transporter; Tourette's syndrome

Indexed keywords

[2 [[2 [[[3 (4 CHLOROPHENYL) 8 METHYL 8 AZABICYCLO[3.2.1]OCT 2 YL]METHYL](2 MERCAPTOETHYL)AMINO]ETHYL]AMINO]ETHANETHIOLATO]OXOTECHNETIUM TC 99M; DOPAMINE TRANSPORTER;

ADULT; ARTICLE; BRAIN; CAMERA; CAUDATE NUCLEUS; CLINICAL ARTICLE; CLINICAL FEATURE; COLLIMATOR; CONTROLLED STUDY; CORPUS STRIATUM; CORRELATION ANALYSIS; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DOPAMINERGIC ACTIVITY; DOPAMINERGIC SYSTEM; DOPAMINERGIC TRANSMISSION; FUNCTIONAL DISEASE; GILLES DE LA TOURETTE SYNDROME; HUMAN; IMAGE ANALYSIS; IMAGE DISPLAY; MALE; NERVE CELL NETWORK; NEUROIMAGING; OCCIPITAL CORTEX; PUTAMEN; RECEPTOR INTRINSIC ACTIVITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STATISTICAL ANALYSIS; TIC;

ADULT; BRAIN; CASE-CONTROL STUDIES; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; FEMALE; HUMANS; MALE; NEURONS; ORGANOTECHNETIUM COMPOUNDS; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOURETTE SYNDROME; TROPANES;

EID: 33748756683     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/01.mnm.0000239485.53780.16     Document Type: Article

References (28)

1. Robertson MM. Annotation: Gilles de la Tourette syndrome-an update. J Child Psychol Psychiatry 1994; 35:597-611.
2. Shapiro E, Shapiro AK, Fulop G, Hubbard M, Mandeli J, Nordlie J, et al. Controlled study of haloperidol, pimozide and placebo for the treatment of Gilles de la Tourette's syndrome. Arch Gen Psychiatry 1989; 46:722-730.
3. Golden GS. The relationship between stimulant medication and tics. Pediatr Ann 1988; 17:405-408.
4. Gainetdinov RR, Jones SR, Fumagalli F, Wightman RM, Caron MG. Re-evaluation of the role of the dopamine transporter in dopamine system homeostasis. Brain Res Brain Res Rev 1998; 26:148-153.
5. 123I]beta-CIT SPECT imaging of striatal dopamine transporter binding in Tourette's disorder. Am J Psychiatry 1995; 152:1359-1361.
6. Muller-Vahl KR, Berding G, Brucke T, Kolbe H, Meyer GJ, Hundeshagen H, et al. Dopamine transporter binding in Gilles de la Tourette syndrome. J Neurol 2000; 247:514-520.
7. Singer HS, Hahn IH, Moran TH. Abnormal dopamine uptake sites in postmortem striatum from patients with Tourette's syndrome. Ann Neurol 1991; 30:558-562.
8. Ernst M, Zametkin AJ, Jons PH, Matochik JA, Pascualvaca D, Cohen RM. High presynaptic dopaminergic activity in children with Tourette's disorder. J Am Acad Child Adolesc Psychiatry 1999; 38:86-94.
9. 123I]IPT SPECT in drug-naive children with Tourette's disorder. Psychiatry Res 2004; 130:85-95.
10. Heinz A, Knable MB, Wolf SS, Jones DW, Gorey JG, Hyde TM, et al. Tourette's syndrome: [I-123]beta-CIT SPECT correlates of vocal tic severity. Neurology 1998; 51:1069-1074.
11. Stamenkovic M, Schindler SD, Asenbaum S, Neumeister A, Willeit M, Willinger U, et al. No change in striatal dopamine re-uptake site density in psychotropic drug naive and in currently treated Tourette's disorder patients: a [(123)I]-beta-CIT SPECT-study. Eur Neuropsychopharmacol 2001; 11:69-74.
12. Meyer P, Bohnen NI, Minoshima S, Koeppe RA, Wernette K, Kilbourn MR, et al. Striatal presynaptic monoaminergic vesicles are not increased in Tourette's syndrome. Neurology 1999; 53:371-374.
13. 123I]FP-CIT: a potent radioligand for imaging of dopamine transporters. Eur J Nucl Med 1998; 25:24-30.
14. 99mTc-TRODAT-1 SPET for the evaluation of Parkinson's disease. Eur J Nucl Med Mol Imaging 2004; 31:155-161.
15. Leckman JF, Riddle MA, Hardin MT, Ort SI, Swartz KL, Stevenson J, et al. The Yale Global Tic Severity Scale: initial testing of a clinician-rated scale of tic severity. J Am Acad Child Adolesc Psychiatry 1989; 28:566-573.
16. Krause KH, Dresel S, Krause J, Kung HF, Tatsch K, Lochmuller H. Elevated striatal dopamine transporter in a drug naive patient with Tourette syndrome and attention deficit/hyperactivity disorder: positive effect of methylphenidate. J Neurol 2002; 249:1116-1118.
17. 123I]FP-CIT/SPECT study. Acta Psychiatr Scand 2004; 109:140-146.
18. Muller-Vahl KR, Berding G, Kolbe H, Meyer GJ, Hundeshagen H, Dengler R, et al. Dopamine D2 receptor imaging in Gilles de la Tourette syndrome. Acta Neurol Scand 2000; 101:165-171.
19. Peterson BS, Staib L, Scahill L, Zhang H, Anderson C, Leckman JF, et al. Regional brain and ventricular volumes in Tourette syndrome. Arch Gen Psychiatry 2001; 58:427-440.
20. 99mTc-TRODAT-1 imaging. J Nucl Med 2001; 42:1303-1308.
21. 123I]IBZM in normal and 6-OHDA-lesioned formosan rock monkeys. Nucl Med Biol 2002; 29:561-567.
22. Asenbaum S, Brucke T, Pirker W, Podreka I, Angelberger P, Wenger S, et al. Imaging of dopamine transporters with iodine-123-beta-CIT and SPECT in Parkinson's disease. J Nucl Med 1997; 38:1-6.
23. 99mTc-TRODAT-1. Eur J Nucl Med Mol Imaging 2004; 31:1119-1127.
24. 99mTc-TRODAT-1 SPECT imaging in differentiating patients with idiopathic Parkinson's disease from healthy subjects. J Nucl Med 2004; 45:393-401.
25. Peterson BS. Neuroimaging studies of Tourette syndrome: a decade of progress. Adv Neuro 2001; 185:179-196.
26. Turjanski N, Sawle GV, Playford ED, Weeks R, Lammerstma AA, Lees AJ, et al. PET studies of the presynaptic and postsynaptic dopaminergic system in Tourette's syndrome. J Neurol Neurosurg Psychiatry 1994; 57:688-692.
27. Huang WJ, Yao WJ, Wey SP, Ting G. Reproducibility of Tc-99m TRODAT-1 SPECT measurement of dopamine transporters in Parkinson's disease. J Nucl Med 2004; 45:207-213.
28. Mozley PD, Acton PD, Barraclough ED, Plossl K, Gur RC, Alavi A, et al. Effects of age on dopamine transporters in healthy humans. J Nucl Med 1999; 40:1812-1817.